详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

The Function of Ubiquitination in T-Cell Development

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Center for Immunology and Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. [2]Center for Immunology and Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. [3]Chongqing International Institute for Immunology, Chongqing, China.

出处：

DOI：

ISSN：

关键词： T cell development Ubiquitination Treg development Negative and positive selection Thymic epithelial cell (TEC)

摘要：

Thymus is an important primary lymphoid organ for T cell development. After T-lineage commitment, the early thymic progenitors (ETPs) develop into CD4-CD8- (DN), CD4+CD8+ (DP) and further CD4+ SP or CD8+ SP T cells. Under the help of thymic epithelial cells (TEC), dendritic cell (DC), macrophage, and B cells, ETPs undergo proliferation, T cell receptor (TCR) rearrangement, β-selection, positive selection, and negative selection, and thus leading to the generation of T cells that are diverse repertoire immunocompetent but not self-reactive. Additionally, some self-reactive thymocytes give rise to Treg under the help of TEC and DC. The regulation of T cell development is complicated. As a post-translational modification, ubiquitination regulates signal transduction in diverse biological processes. Ubiquitination functions in T cell development through regulating key signal pathway or maturation and function of related cells. In this review, the regulation of T cell development by ubiquitination is summarized and discussed.© 2024. The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

语种：

PubmedID：

第一作者：

第一作者机构： [1]Center for Immunology and Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

通讯作者：

通讯机构： [2]Center for Immunology and Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. [3]Chongqing International Institute for Immunology, Chongqing, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Ubiquitination of Immune System and Cancer Therapy [2]Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer [3]Dietary apigenin potentiates the inhibitory effect of interferon-alpha on cancer cell viability through inhibition of 26S proteasome-mediated interferon receptor degradation [4]The F-box protein FBXL18 promotes glioma progression by promoting K63-linked ubiquitination of Akt [5]NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression [6]CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion [7]UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination [8]Stratified ubiquitination of RIG-I creates robust immune response and induces selective gene expression [9]Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. [10]Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7